PA-Anatomical Pathology

Medicine & Life Sciences

1. Neoplasms 100%
2. Biopsy 52%
3. Adenocarcinoma 46%
4. Pathology 46%
5. Mutation 45%
6. Renal Cell Carcinoma 43%
7. Pathologists 42%
8. Carcinoma 34%
9. Cell Biology 28%
10. Kidney 27%
11. Acute Myeloid Leukemia 27%
12. Endometrial Neoplasms 26%
13. Multiparametric Magnetic Resonance Imaging 26%
14. Neoplasm Metastasis 23%
15. Immunohistochemistry 23%
16. Squamous Cell Carcinoma 22%
17. Prostatic Neoplasms 21%
18. Leukemia 21%
19. Prostate 20%
20. Pediatrics 18%
21. Germ Cell and Embryonal Neoplasms 17%
22. Bone Marrow 17%
23. Lymphoma 17%
24. High-Throughput Nucleotide Sequencing 17%
25. Lymph Nodes 17%
26. Endometrioid Carcinoma 16%
27. Sarcoma 16%
28. Catenins 16%
29. Hyperplasia 16%
30. Biomarkers 15%
31. Carcinoma, Intraductal, Noninfiltrating 14%
32. Therapeutics 14%
33. Glandular and Epithelial Neoplasms 14%
34. Survival 14%
35. Keratins 14%
36. Neuroendocrine Tumors 14%
37. Uterine Cervical Neoplasms 14%
38. Tumor-Infiltrating Lymphocytes 14%
39. Papillary Thyroid Cancer 14%
40. Fluorescence In Situ Hybridization 14%
41. Histology 13%
42. Muscles 13%
43. Genotype 13%
44. Genes 13%
45. Precursor Cell Lymphoblastic Leukemia-Lymphoma 13%
46. Esophageal Squamous Cell Carcinoma 13%
47. Phenotype 13%
48. Prostatectomy 13%
49. Endometrial Stromal Tumors 13%
50. Gene Fusion 12%
51. Ligands 12%
52. Salivary Gland Neoplasms 12%
53. Plasmablastic Lymphoma 12%
54. Radiotherapy 12%
55. Crohn Disease 12%
56. Inflammation 11%
57. T-Lymphocytes 11%
58. Adenocarcinoma in Situ 11%
59. Central Nervous System 11%
60. Recurrence 11%
61. Skeletal Muscle 11%
62. Hematologic Neoplasms 10%
63. Staining and Labeling 10%
64. Liver 10%
65. Epigenomics 10%
66. Lung 10%
67. Frozen Sections 10%
68. Prostate-Specific Antigen 10%
69. Proteins 10%
70. Growth 10%
71. Mucoepidermoid Carcinoma 10%
72. Neck 10%
73. Adrenocortical Carcinoma 10%
74. Cytogenetics 10%
75. Salivary Ducts 10%
76. Myelodysplastic Syndromes 9%
77. Squamous Intraepithelial Lesions 9%
78. Molecular Biology 9%
79. Differential Diagnosis 9%
80. Neuroendocrine Carcinoma 9%
81. Reticulum 9%
82. Mast Cells 9%
83. Seminoma 9%
84. Serum 9%
85. RNA Sequence Analysis 9%
86. Chromosomes, Human, Pair 1 9%
87. Glomerulonephritis 9%
88. Hemangiosarcoma 9%
89. Molecular Weight 9%
90. Glioblastoma 9%
91. Salivary Glands 9%
92. Karyotype 9%
93. Swine 8%
94. Observer Variation 8%
95. Terminology 8%
96. Immunotherapy 8%
97. Transplants 8%
98. Testicular Germ Cell Tumor 8%
99. Stomach 8%
100. Tumor Microenvironment 8%